Physician profile
Mini Varughese
NPI 1811330624
$1,986.27
in general payments reported to CMS, 2019-2025
9 companies · $1,298 in 2025
The $1,298 reported for 2025 was more than what 88% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $27.38 · 2023: $173 · 2024: $488 · 2025: $1,298.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,959.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,958.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,108.93 | 2021-2025 | Cardiomems, Jot Dx, Dragonfly Opstar |
| Amgen INC. | $288.05 | 2024-2025 | Repatha, Repatha |
| Bridgebio Pharma, INC. | $204.63 | 2025 | Attruby |
| Cardiva Medical, INC. | $146.07 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Medtronic, INC. | $77.22 | 2024 | Cobalt Dr Mri Surescan |
| Abiomed | $50.97 | 2024-2025 | Impella |
| Bracco Diagnostics INC. | $50.24 | 2025 | |
| Medical Device Business Services, INC. | $42.75 | 2025 | Vistaseal |
| Ethicon US, LLC | $17.41 | 2025 | Stratafix, Dermabond, Surgicel Nu-Knit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mini Varughese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.